The mastcell, director of chronic pelvic pain orchestra: implications for the gynaecologist
The mastcell, director of chronic pelvic pain orchestra: implications for the the gynaecologist
Plenary lecture - XIX World Congress of Gynecology and Obstetrics, organized by the International Federation of Gynecology and Obstetrics (FIGO), October 4-9, 2009, Cape Town, South Africa
Increasing evidence supports the prominent role of up-regulated mastcells (MC's) in the maintenance of chronic inflammation and in the shifting from nociceptive to neuropathic pain in the affected tissues, contributing to chronic pelvic pain (CPP).
New therapeutic lines consider reduction of agonists and/or using drugs (“antagonists”) that can down-regulated the release of pro-inflammatory, angiogenic and neurotrophic factors from the mastcells.
Gynaecologist’ may improve CPP by understanding the pathophysiology of MCs in chronic inflammation and addressing it in a multimodal therapeutic process.
- Neuropathic Pain
- Nociceptive Pain
- Chronic Pelvic Pain
- Irritable Bowel Syndrome
- Pain System
- Vulvar Vestibulitis / Provoked Vestibulodynia
© 2011 - Alessandra Graziottin Foundation
FAIR USE: The content of this paper can be downloaded, printed and read for strictly personal and non-profit use. Any citation for didactic and/or scientific purpose must quote the title of the document, the name of the author(s), the data of the book or journal, and the URL of the site (www.fondazionegraziottin.org).
WARNING: Every therapy must be discussed, tailored, prescribed and monitored by the M.D. personally consulted. Every information presented in this website can not surrogate the personal relationship with the caring physician nor be utilized without specific medical advice.